Therapeutic agent

Low-Dose Naltrexone (LDN)

Also known as: Low-Dose Naltrexone (LDN)

PreliminaryEvidence level
2Registered trials
3Conditions
1Study references

Evidence Summary

Evidence Level
Preliminary
Mechanism
Enrollment: Estimated, Immunomodulatory, Repurposed Drug, Sponsor Type: Other
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 2 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

2 trial(s) registered

NCT IDTitlePhaseStatus
NCT06366724LIFT: Life Improvement TrialPhase 2Recruiting
NCT07285473Low-Dose Naltrexone For ME/CFS: Dose-FindingPhase 2Not yet recruiting

Key Studies / References